SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-18-003579
Filing Date
2018-08-29
Accepted
2018-08-29 17:51:13
Documents
1
Period of Report
2018-08-23

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 5711
  Complete submission text file 0001062993-18-003579.txt   7067
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 167 EXECUTIVE DRIVE MANHASSET HILLS NY 11040
Business Address
Gitman Paul (Reporting) CIK: 0001375378 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34236 | Film No.: 181045119